ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 35 filers reported holding ESSA PHARMA INC in Q3 2023. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $76,410 | -90.3% | 28,300 | -89.3% | 0.00% | -90.9% |
| Q1 2023 | $785,776 | +17.9% | 264,571 | 0.0% | 0.01% | +10.0% |
| Q4 2022 | $666,719 | -93.3% | 264,571 | -24.1% | 0.01% | -92.4% |
| Q2 2021 | $9,957,000 | -37.8% | 348,524 | -36.8% | 0.13% | -44.1% |
| Q1 2021 | $16,010,000 | +28.0% | 551,122 | -47.4% | 0.24% | +16.8% |
| Q4 2020 | $12,509,000 | +377.1% | 1,048,524 | +175.9% | 0.20% | +274.1% |
| Q3 2020 | $2,622,000 | – | 380,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |